Protheragen is an innovative company specialising in the development of antibody drugs. With the aid of our state-of-the-art GeniusAb™ platform, we assist our clients in the discovery and development of fully human single domain antibodies, which transforms the commercialization process for antibody therapeutics.
The focal point of this platform is the highly innovative GeniusAb™ mouse model which is developed for the production of fully human single domain antibodies. Such advanced approach allows to generate antibodies with precise specificity and minimal immunogenicity, thus making an important contribution in the field of therapeutic antibodies development.
Platform Advantages
- Introduction of human immunoglobulin heavy chain genes
- Robust immune responses against multiple antigens
- Expansion of single domain antibodies repertoire
- Do not require in vitro humanization